e-Proteins Information

Revolutionizing Binding Solutions: e-Proteins at the Forefront As a trailblazer in avidin derivatives production, e-Proteins leads the global stage, providing optimal alternatives to streptavidin. Our innovative approach is focused on shaping the future of binding proteins, backed by over a decade of dedicated research and development. Within our state-of-the-art research facility, renowned scientists collaborate on groundbreaking projects aimed at addressing the challenges posed by traditional streptavidin. NAX - Non-Specific Binding Protein: Solving the issue of non-specific binding, NAX stands as a superior alternative, setting new benchmarks in specificity. UltraCoat50 - High Binding Capacity for Purification: Designed for purification applications, UltraCoat50 boasts an unparalleled binding capacity, outperforming traditional streptavidin. UltraCoat70 - High Binding Capacity for Detection: Specifically engineered for detection, UltraCoat70 surpasses streptavidin with superior binding properties, making it ideal for diagnostic tests. Our commitment to advancing product performance encompasses all facets, with a particular emphasis on achieving exceptional protein binding capacity. UltraCoat70: This derivative not only outshines streptavidin in non-specific binding but also offers heightened detection capabilities. With a multi-layer structure, UltraCoat70 outperforms streptavidin by an impressive 130%, ensuring superior performance across a wide pH range. 3-HRP Conjugate: e-Proteins is on the cutting edge of developing a novel conjugate binding protein utilizing HorseRadish Peroxidase (HRP). The groundbreaking 3-HRP conjugate not only facilitates detection akin to other HRP conjugates but also introduces a quantification dimension. At e-Proteins, we are not just redefining binding solutions; we are pioneering the next generation of binding proteins that elevate performance, specificity, and versatility in diverse applications.